Sara Tolaney
@stolaney1
Followers
12K
Following
23K
Media
411
Statuses
5K
Chief, Division of Breast Oncology @DanaFarber Tennis fan Mother of two teenage girls
Boston. MA
Joined December 2015
RT @SABCSSanAntonio: Applications due 11:59 PM CT today:Presenting or senior authors of submitted #SABCS25 abstracts who are at the level o….
0
2
0
RT @oncodaily: Patient-Level Meta-Analysis of HER2DX in Early-Stage HER2-Positive Breast Cancer - Aleix Prat . @G_Villacampa @stolaney1 . h….
0
2
0
RT @DanaFarber: We’re proud to be included in @Newsweek’s America’s Greatest Workplaces by State 2025 list. This recognition reflects our o….
0
5
0
RT @PTarantinoMD: Very glad to contribute to this large (11 trials, 2500 pts) meta-analysis led by @G_Villacampa, now out in @TheLancetOnco….
0
18
0
RT @LobularIreland: Thank you @GuiNaderMarta for sharing this newly published study .Association of HER2-low with clinicopathological featu….
0
2
0
RT @hospitalclinic: 🧪 Un nou estudi valida el valor pronòstic del test HER2DX en el #càncer de mama HER2 positiu. 👨🔬 Investigadors del #Cl….
0
1
0
RT @DFCI_BreastOnc: The #HarvardBreastCancerCourse starts on Thursday!.📅July 17 & 18.📍Westin Copley Place, Boston, MA.The @harvardmed #Brea….
0
8
0
RT @DrYukselUrun: (Breast) Cancer care shouldn’t be a luxury. We lose lives not just to cancer, but to lack of access, high costs, and tria….
0
17
0
RT @medoncodoc: 📢 HER2DX Validated as a Prognostic Tool in Early HER2+ Breast Cancer.🔬 Largest individual patient-level meta-analysis (n=2,….
0
1
0
RT @TheLancetOncol: 🔴Online now: HER2DX and survival outcomes in early-stage HER2-positive #breastcancer: an individual patient-level meta-….
0
15
0
RT @BIGxResearch: 📢 New open-access article in npj Breast Cancer, co-authored by BIG’s leadership, explores the challenges of academic clin….
0
10
0
RT @DFCI_BreastOnc: Join @DanaFarber's Paolo Tarantino, MD (@PTarantinoMD) at the free, virtual EMBRACE Patient Forum for updates on treatm….
0
6
0
RT @DFCI_BreastOnc: @DFCI_BreastOnc is leading a trial on the use of #ColdCaps in preventing #HairLoss with novel #BreastCancer therapies,….
0
1
0
RT @DFCI_BreastOnc: Check out this recent paper on #InflammatoryBreastCancer, it examines the clinicogenomic characterization of #IBC. 👉h….
0
19
0
RT @nlinmd: What happens when you query chatGPT with 362 breast cancer cases?. -46% responses differed from breast cancer expert opinion. -….
0
43
0
RT @DFCI_BreastOnc: Here's the most recent #BreastCancer Research Digest - a summary of last week’s publications from select high-impact jo….
0
10
0
RT @OncLive: ICYMI: @PTarantinoMD of @DanaFarber details the role of ADCs in HER2-positive #breastcancer, along with persisting unmet needs….
0
5
0
RT @montypal: Hats off to @ReginaBarCar who (w @ZeynepZengin @YaleIMed) put together a beautiful overview of #microbiome modulation for the….
0
28
0